Low-dose interleukin-2 therapy for the treatment of systemic lupus erythematosus
2019
Purpose of reviewTo provide an overview behind the concept and recent advances of low-dose interleukin-2 (IL-2) therapy in systemic lupus erythematosus (SLE).Recent findingsA disruption of regulatory T cell homeostasis caused by an acquired deficiency of IL-2 is a crucial event in the pathogenesis o
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
33
References
14
Citations
NaN
KQI